Insider Trading & Ownership of Carole Ho

Location: South San Francisco, CA
Summary: The estimated net worth of Carole Ho is at least $4,404,504 dollars as of 06 Jan 2026. Carole Ho is the Chief Medical Officer of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $3.53M. Carole Ho is the Director of Beam Therapeutics Inc. and owns shares of Beam Therapeutics Inc. (BEAM) stock worth about $564K. Carole Ho is the Director of Royalty Pharma plc and owns shares of Royalty Pharma plc (RPRX) stock worth about $306.7K.
Signature: /s/ Jonathan Groff for Carole Ho, pursuant to authorization attached
All Insider Reports: All Insider Reports

Notify me when Carole Ho files a new Insider Trading report.

Ownership of Carole Ho

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
DNLI	Denali Therapeutics Inc.	Chief Medical Officer	$3,533,804	-$51,684	-1.4%	12 Aug 2025
BEAM	Beam Therapeutics Inc.	Director	$563,982			04 Jun 2025
RPRX	Royalty Pharma plc	Director	$306,718			31 Jul 2025
LLY	ELI LILLY & Co	EVP & Pres, Lilly Neuroscience				31 Dec 2025
NGM	NGM BIOPHARMACEUTICALS INC	Director				05 Apr 2024

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.